Freya Pharma Solutions
Freya Pharma Solutions is a late clinical stage company focused on developing effective pharmaceutical therapies for FSIAD, building upon fifteen years of solid research. The company has two compounds in development, Lybrido and Lybridos, to address the range of potential causes of FSIAD. Freya aims to offer patients a convenient, personalized ‘on demand’ solution for this recognized unmet medical need.
Freya wanted support with a rebrand after acquiring all IP for their pharmaceutical products from another company.